Cargando…
A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation
In this study, a formulation of Bordetella pertussis proteoliposome (PLBp), diphtheria, and tetanus toxoids and alum (DT-PLBp) was evaluated as a trivalent vaccine candidate in BALB/c mice. Vaccine-induced protection was estimated using the intranasal challenge for pertussis and enzyme-linked immuno...
Autores principales: | Castillo, Sonsire Fernández, Chovel, Mario Landys, Hernández, Niurka Gutiérrez, González, Lorena Corcho, Blanco, Amaya, Hernández, Daily Serrano, Medina, Mildrey Fariñas, Tito, Maydelis Álvarez, Quiñoy, José Luis Pérez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969282/ https://www.ncbi.nlm.nih.gov/pubmed/27489808 http://dx.doi.org/10.7774/cevr.2016.5.2.175 |
Ejemplares similares
-
A proteoliposome formulation derived from Bordetella pertussis induces protection in two murine challenge models
por: Fernández, Sonsire, et al.
Publicado: (2013) -
Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
por: Ammar, Hussam
Publicado: (2011) -
Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
por: Kumar, Vivek, et al.
Publicado: (2018) -
Barriers to Receipt of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Among Mothers of Infants Aged <4 Months with Pertussis — California, 2016
por: New, Sarah, et al.
Publicado: (2018) -
SARS – CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis)
por: Ietto, Giuseppe
Publicado: (2020)